Showing results (11-20 of 86) with videos related to
Sort By:
Pageof 9
Hematology. American Society of Hematology. Education Program|November 26, 2002
Novel therapeutic approaches in sickle cell diseaseMark C Walters, Arthur W Nienhuis, Elliott VichinskySeminars in Hematology|January 30, 2010
Transplant outcomes in bone marrow failure syndromes and hemoglobinopathiesMargaret L MacMillan, Mark C Walters, Eliane GluckmanHematology. American Society of Hematology. Education Program|November 10, 2001
Bone Marrow Transplantation for Non-Malignant DiseaseKeith M. Sullivan, Robertson Parkman, Mark C. WaltersCurrent Opinion in Hematology|October 21, 2006
Clinical hemoglobinopathies: iron, lungs and new bloodClaudia R Morris, Sylvia T Singer, Mark C WaltersHematology/Oncology Clinics of North America|November 18, 2022
Allogeneic Transplant and Gene Therapy: Evolving Toward a CureR AdeBisi Lawal, Mark C Walters, Courtney D FitzhughAmerican Journal of Hematology|November 27, 2023
Defining curative endpoints for sickle cell disease in the era of gene therapy and gene editingFranco Locatelli, Selim Corbacioglu, William Hobbs, et al.Frontiers in Pharmacology|January 29, 2015
In utero hematopoietic cell transplantation for hemoglobinopathiesS Christopher Derderian, Cerine Jeanty, Mark C Walters, et al.Pediatric Blood & Cancer|June 9, 2007
Transfusional iron burden and liver toxicity after bone marrow transplantation for acute myelogenous leukemia and hemoglobinopathiesWasil Jastaniah, Paul Harmatz, Zahra Pakbaz, et al.Annals of the New York Academy of Sciences|December 13, 2005
Treatment of hepatitis C virus infection in thalassemiaEllen Butensky, Zahra Pakbaz, Drucilla Foote, et al.Transplantation and Cellular Therapy|October 21, 2022
Enrollment Lessons from a Biological Assignment Study of Marrow Transplantation versus Standard Care for Adolescents and Young Adults with Sickle Cell Disease: Considerations for Future Gene and Cellular Therapy TrialsLakshmanan Krishnamurti, Donna Neuberg, Keith M Sullivan, et al.Pageof 9